Literature DB >> 18401196

Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.

Shuihong Zhou1, Shenqing Wang, Qiuliang Wu, Jun Fan, Qinying Wang.   

Abstract

OBJECTIVE: The aim of this study was to determine the biological significance of glucose transporter (Glut)-1 and Glut-3 expression in head and neck carcinoma (HNC).
METHODS: We detected expression of Glut-1 and -3 in 38 HNCs and analyzed the relationship between increased expression and the biological behavior of HNCs.
RESULTS: The gene expression levels of Glut-1 and -3 in HNCs were significantly higher than those in adjacent cancer tissues or in normal tissues. The GLUT-1 gene level was correlated with the lymph node metastasis and clinical stage of 38 HNCs, and the GLUT-3 gene level was correlated with the lymph node metastasis of 38 HNCs. Of the 38 cases, 30 showed positive expression of Glut-1 protein. The Glut-1 protein expression level was related to the lymph node metastasis and clinical stage of 38 HNCs. However, there was no case that expressed Glut-3 protein. The high expression of Glut-1 gene and protein was associated with poor survival in the HNCs. GLUT-3 gene expression was not associated with the prognosis of HNCs.
CONCLUSIONS: GLUT-1 gene expression level and protein expression were correlated with lymph node metastasis, poor survival and clinical stage of HNCs. The GLUT-3 gene expression level was high in HNCs, and its expression was associated with an increased incidence of lymph node metastasis of HNCs. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18401196     DOI: 10.1159/000124293

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  19 in total

1.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

2.  Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Authors:  M A Kocdor; H Kocdor; J S Pereira; J E Vanegas; I H Russo; J Russo
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  Diabetes mellitus and hyperglycemia are associated with inferior oncologic outcomes in adrenocortical carcinoma.

Authors:  Sean M Wrenn; T K Pandian; Rajshri M Gartland; Zhi Ven Fong; Matthew A Nehs
Journal:  Langenbecks Arch Surg       Date:  2021-02-01       Impact factor: 3.445

4.  Glucose conjugation for the specific targeting and treatment of cancer.

Authors:  Emilia C Calvaresi; Paul J Hergenrother
Journal:  Chem Sci       Date:  2013-06       Impact factor: 9.825

Review 5.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

6.  Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.

Authors:  Xiao-Hong Wu; Su-Ping Chen; Jian-Ying Mao; Xue-Xian Ji; Hong-Tian Yao; Shui-Hong Zhou
Journal:  Oncol Lett       Date:  2012-09-26       Impact factor: 2.967

7.  Recurrent prognostic factors and expression of GLUT-1, PI3K and p-Akt in adenoid cystic carcinomas of the head and neck: Clinicopathological features and biomarkers of adenoid cystic carcinoma.

Authors:  Jin Fang; Yang-Yang Bao; Shui-Hong Zhou; Xing-Mei Luo; Hong-Tian Yao; Jian-Feng He; Qin-Ying Wang
Journal:  Oncol Lett       Date:  2012-09-05       Impact factor: 2.967

Review 8.  Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.

Authors:  Farzan Siddiqui; Min Yao
Journal:  World J Radiol       Date:  2014-06-28

9.  Potential role of sugar transporters in cancer and their relationship with anticancer therapy.

Authors:  Moisés Blanco Calvo; Angélica Figueroa; Enrique Grande Pulido; Rosario García Campelo; Luís Antón Aparicio
Journal:  Int J Endocrinol       Date:  2010-07-18       Impact factor: 3.257

10.  Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.

Authors:  Katarzyna Starska; Ewa Forma; Paweł Jóźwiak; Magdalena Bryś; Iwona Lewy-Trenda; Ewa Brzezińska-Błaszczyk; Anna Krześlak
Journal:  Tumour Biol       Date:  2014-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.